Stockscreener 앱 받기
7.47
3.11%
-0.24
시간 외 거래:
7.45
-0.02
-0.27%
전일 마감가:
$7.71
열려 있는:
$7.71
하루 거래량:
90,843
Relative Volume:
0.53
시가총액:
$202.71M
수익:
$56.13M
순이익/손실:
$-14.67M
주가수익비율:
-10.09
EPS:
-0.74
순현금흐름:
$-9.13M
1주 성능:
-5.68%
1개월 성능:
+0.81%
6개월 성능:
+6.11%
1년 성능:
+86.75%
1일 변동 폭
$7.3222
$7.72
1주일 범위
$7.3222
$8.1139
52주 변동 폭
$3.535
$9.40
Journey Medical Corp Stock (DERM) Company Profile
명칭
Journey Medical Corp
전화
480-434-6670
주소
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
DERM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.47 | 209.22M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
125.90 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.95 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
496.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | H.C. Wainwright | Buy |
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-28 | 재개 | ROTH MKM | Buy |
| 2021-12-07 | 개시 | B. Riley Securities | Buy |
Journey Medical Corp 주식(DERM)의 최신 뉴스
Fourteen new option listings on November 12th - MSN
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33% - Yahoo Finance
10 Best Travel Insurance Companies For 2026 - Forbes
Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Earnings Beat: Why Profound Medical Corp stock attracts high net worth investorsMarket Trend Review & Risk Controlled Swing Trade Alerts - moha.gov.vn
Aug Weekly: Can Quipt Home Medical Corp. stock reach $100 price targetPortfolio Return Report & Reliable Entry Point Alerts - ulpravda.ru
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher – What’s Next? - Defense World
How Orthofix Medical Inc. stock performs in interest rate cycles2025 Volatility Report & Accurate Entry and Exit Point Alerts - ulpravda.ru
Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM - MarketBeat
Is Journey Medical Corporation stock cheap at current valuationWeekly Trade Review & Target Return Focused Stock Picks - Улправда
Journey Medical (NASDAQ:DERM) Trading 2.1% HigherWhat's Next? - MarketBeat
How Journey Medical Corporation stock benefits from tech adoptionWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Can Zhejiang Taimei Medical Technology Co. Ltd. (A2V) stock ride next bull market cycleMarket Sentiment Summary & Entry Point Confirmation Alerts - Улправда
Can Unidoc Health Corp. (L7T) stock beat analyst consensusJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - Улправда
Is Journey Medical Corporation stock a buy on dipsEarnings Miss & Technical Analysis for Trade Confirmation - Улправда
How analysts rate Quipt Home Medical Corp. stock todayWeekly Gains Report & Accurate Trade Setup Notifications - Улправда
Fortress Biotech (Nasdaq: FBIO): FDA accepts Class 1 resubmission, CUTX-101 PDUFA Jan. 14, 2026 - Stock Titan
Fortress Biotech (NASDAQ: FBIO) extends loan maturity and grants warrants - Stock Titan
Journey Medical announces results from phase 1 trial of DFD-29 - MSN
Layoff Tracker: Pfizer, Geron Downsize To Streamline Costs - BioSpace
Our Products | Full Products and Solutions List | Abbott U.S. - Abbott
Minocycline study shows no microbiome disruption after 16-week use By Investing.com - Investing.com Nigeria
Journey Medical announces results from Phase 1 trial of DFD-29 - TipRanks
DERM FinancialsIncome Statement - Quiver Quantitative
Minocycline study shows no microbiome disruption after 16-week use - Investing.com India
Journey Medical Corporation Reports Positive Phase 1 Trial Results for Emrosi, Meeting All Primary Objectives with No Safety Issues - Quiver Quantitative
Journey Medical (Nasdaq: DERM) posts Phase 1 Emrosi data on 16-week microbiome profile - Stock Titan
Aleen Inc. Introduces Wellness AI: A Journey into Self-Discovery, Not Medical Diagnosis - TradingView — Track All Markets
DERM Stock On The Rise: Worth Watching As Emrosi Adoption Expands - RTTNews
Journey Medical (DERM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Price Action: Why Omega Healthcare Investors Inc. stock attracts high net worth investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Published on: 2025-11-27 22:02:05 - moha.gov.vn
Aug Mood: Will Franco Nevada Corporation (3FO) stock outperform global peers2025 Momentum Check & Real-Time Buy Signal Alerts - BỘ NỘI VỤ
Journey Strategic Wealth LLC Takes $250,000 Position in HCA Healthcare, Inc. $HCA - MarketBeat
VITAS Healthcare (CHE) shares caregiver Stacy Noland's hospice-at-home story in new video - Stock Titan
Journey Strategic Wealth LLC Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Envestnet Asset Management Inc. Decreases Holdings in Journey Medical Corporation $DERM - MarketBeat
New VITAS® Healthcare Video Honors Caregiver's Journey and the Power of Hospice at Home - Yahoo Finance
Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators - Markets Mojo
Head-To-Head Comparison: Dyne Therapeutics (NASDAQ:DYN) versus Journey Medical (NASDAQ:DERM) - Defense World
Analysts Are Bullish on These Healthcare Stocks: Nano-X Imaging (NNOX), Exact Sciences (EXAS) - The Globe and Mail
Will Journey Medical Corporation stock outperform international peersQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Will Journey Medical Corporation stock see insider buyingMarket Growth Report & Low Volatility Stock Recommendations - newser.com
What Makes Journey Medical Corporation (DERM) a Good Investment? - Yahoo! Finance Canada
Detecting price anomalies in Journey Medical Corporation with AIEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
HC Wainwright Forecasts Journey Medical FY2025 Earnings - Defense World
Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Fortress Biotech reports NDA resubmission for Menkes disease treatment - Investing.com
FY2025 EPS Estimates for Journey Medical Reduced by B. Riley - MarketBeat
FY2025 EPS Forecast for Journey Medical Decreased by Analyst - MarketBeat
Journey Medical Corp (DERM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Journey Medical Corp 주식 (DERM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Maraoui Claude | President & CEO |
May 02 '25 |
Sale |
6.84 |
4,834 |
33,065 |
2,348,313 |
| Benesch Joseph | CFO |
May 02 '25 |
Sale |
6.84 |
2,409 |
16,478 |
203,557 |
| Alloush Ramsey | COO |
May 02 '25 |
Sale |
6.84 |
2,857 |
19,542 |
504,817 |
| Maraoui Claude | President & CEO |
Mar 11 '25 |
Sale |
5.01 |
49,271 |
246,848 |
2,003,147 |
| Maraoui Claude | President & CEO |
Mar 06 '25 |
Sale |
5.04 |
25,551 |
128,777 |
2,067,323 |
| Maraoui Claude | President & CEO |
Mar 07 '25 |
Sale |
5.01 |
14,905 |
74,674 |
2,052,418 |
| Maraoui Claude | President & CEO |
Mar 04 '25 |
Sale |
5.04 |
28,901 |
145,661 |
2,111,021 |
| Maraoui Claude | President & CEO |
Mar 03 '25 |
Sale |
5.19 |
23,508 |
122,007 |
2,139,922 |
| Maraoui Claude | President & CEO |
Mar 05 '25 |
Sale |
5.13 |
18,147 |
93,094 |
2,092,874 |
| Benesch Joseph | CFO |
Feb 21 '25 |
Sale |
5.19 |
1,365 |
7,084 |
45,966 |
2.19%
0.08%
자본화:
|
볼륨(24시간):